Crossref
Third-generation oral cephalosporins in acute tonsillopharyngitis treatment in outpatient practice: Focus on cefixime
Therapy · 13.05.2026 · 3_2026 · 140-146
DOI: 10.18565/therapy.2026.3.140-146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapy, erschienen am 13.05.2026. Verfasst von L.Z. Bolieva Bolieva und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bolieva, L. B., & Gappoeva, E. G. (2026). Third-generation oral cephalosporins in acute tonsillopharyngitis treatment in outpatient practice: Focus on cefixime. Therapy, 3_2026, 140-146. https://doi.org/10.18565/therapy.2026.3.140-146
Vancouver
Bolieva LB, Gappoeva EG. Third-generation oral cephalosporins in acute tonsillopharyngitis treatment in outpatient practice: Focus on cefixime. Therapy. 2026;3_2026:140-146. doi:10.18565/therapy.2026.3.140-146
BibTeX
@article{Bolieva2026,
author = {Bolieva, L.Z. Bolieva and Gappoeva, E.T. Gappoeva},
title = {Third-generation oral cephalosporins in acute tonsillopharyngitis treatment in outpatient practice: Focus on cefixime},
journal = {Therapy},
year = {2026},
volume = {3_2026},
pages = {140--146},
doi = {10.18565/therapy.2026.3.140-146}
}
EUVIMED